News
NICE backs AbbVie’s Rinvoq for severe active rheumatoid arthritis
The UK’s National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Rinvoq (upadacitinib) for people with previously treated severe active rheumatoid arthritis (RA).